Beta Drugs Limited Approves Allotment of Bonus Equity Shares from CCD Conversion
Beta Drugs Limited announced a key operational update following a meeting of its Board of Directors on August 18, 2026. The Board approved the allotment of bonus equity shares resulting from the conversion of Compulsorily Convertible Debentures (CCDs) into equity shares.The decision detailed that 35,383 Bonus Equity Shares were allotted to the holders of the CCDs. Each share has a face value of INR 10. This transaction marks the culmination of the conversion process from debentures into common equity within the company structure.
BETA Stock Price Movement
Beta Drugs Limited shares are shedding 2.79% as of 2:27 PM today, trading at ₹2365 amidst the active trading sessions. The stock saw a volume count of 39,836 shares in the market so far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.